Table 2.
Pearson correlation (r) between plasma asprosin, oestrogen and progesterone in all women and women who use oral contraceptives (OC) or do not use OCs (non-OC) in the mid-luteal phase
| All women (n = 32) | |||
|---|---|---|---|
| Asprosin | Progesterone | Oestrogen | |
| Asprosin | – | r = 0.418a | r = 0.462b |
| Progesterone | – | r = 0.642b | |
| OC (n = 18) | Non-OC (n = 14) | |||||
|---|---|---|---|---|---|---|
| Asprosin | Progesterone | Oestrogen | Asprosin | Progesterone | Oestrogen | |
| Asprosin | – | r = 0.735b | r = 0.383 | – | r = − 0.008 | r = 0.234 |
| Progesterone | – | r = 0.523a | – | r = 0.517 | ||
Thresholds of 0.1, 0.3 and 0.5 were used to define Pearson correlation coefficients as small, moderate and large, respectively (Cohen 1988)
aCorrelation is significant at the 0.05 level
bCorrelation is significant at the 0.01 level